Virtual Medicinal Product (VMP)
-
Heparin sodium 200units/2ml patency solution ampoules
Name Details
Current Name
Heparin sodium 200units/2ml patency solution ampoules
|
Start Date
31-01-2018
|
End Date
|
Previous Name
Heparin sodium 200units/2ml patency solution ampoules
|
Start Date
14-07-2009
|
End Date
30-01-2018
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Route of administration not applicable
- Form
- Not applicable
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
B01AB01
BNF |
Current BNF
02080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02080100
|
Start Date
10-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36054611000001106 |
29-10-2018 |
|
319659006 |
11-02-2003 |
28-10-2018 |
VMP Ingredients
VMP ingredients table
Heparin sodium |
Based on Ingredient Substance |
|
100 unit |
1 ml |
Name
Heparin sodium
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Heparin
-
VMP
(Current) Heparin sodium 200units/2ml patency ...
Virtual Medicinal Product Pack (VMPP) Information